** Shares of New Jersey-based drug distributor Wellgistics Health WGRX.O rise 9.3% to $2.95 premarket

** Company announces it is collaborating with Protega Pharmaceuticals to increase patient access to Protega's opioid, Roxybond

** Roxybond is indicated for managing severe pain when other treatments are insufficient

** WGRX has fallen 29% since its debut on February 21

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))